| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $238.2M | — | -3.2% |
| Cost of Revenue | $9.7M | — | -25.5% |
| Gross Profit | $228.5M | — | -1.9% |
| R&D Expense | $10.4M | — | -61.5% |
| SG&A Expense | $57.9M | — | +1.1% |
| Operating Income | -$9.5M | — | -147.3% |
| Pre-tax Income | -$9.7M | — | -149.0% |
| Income Tax | -$717K | — | -115.3% |
| Net Income | -$9.0M | — | -159.4% |
| EPS (Basic) | -$0.22 | — | -173.3% |
| EPS (Diluted) | -$0.22 | — | -173.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $244.6M | -19.5% | -36.7% |
| Accounts Receivable | $37.4M | +13.0% | -7.7% |
| Current Assets | $313.3M | -14.5% | -32.7% |
| Total Assets | $1.63B | -3.3% | -10.0% |
| Current Liabilities | $209.2M | -6.0% | -3.2% |
| Long-term Debt | $471.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.9M | — | -475.1% |
| Capital Expenditures | $15.7M | — | +25.1% |
| Investing Cash Flow | -$15.7M | — | -25.6% |
| Financing Cash Flow | -$25.5M | — | -78.1% |
| Free Cash Flow | -$33.6M | — | -114.4% |
| -5.2% |
| Stockholders' Equity | $914.7M | -1.4% | -12.8% |